Epoxy Resin Market Worth $9.2 Billion by 2019

  • Epoxy Resin,chemicals,Market
  • PRNewswire

DALLAS, August 28, 2014 /PRNewswire/ -- According to the new research report "Epoxy Resin market by Application (Coatings, Electronics, Construction, Wind Turbine, Composites, and Adhesives) and Geography - Trends & Forecast to 2019" by MarketsandMarkets, the market of epoxy resin is projected to grow from an estimated $5,995.8 million in 2013 to $9,219.1 million by 2019, with a CAGR of 7.4% between 2014 and 2019.

Browse 80 Market Data Tables and 63 Figures spread through 171 Pages and in-depth TOC on "Epoxy Resin market - Trends & Forecast to 2019".

http://www.marketsandmarkets.com/Market-Reports/epoxy-resins-market-762.html

Early buyers will receive 10% customization on reports.

Epoxy resins are thermosetting polymers and known for their high-quality performance in different industrial applications for corrosion protection, thermal stability, mechanical strength, moisture resistivity, adhesion, and so on. The epoxy resins market is very well correlated to its end-user application industry's growth and its widening reach in industrial applications.

Bisphenol A and Epichlorohydrin are major raw materials in the production of epoxy resins, and any change in the demand and supply of these raw materials could have a major impact on the epoxy resin industry. However, due to rising health concerns related to BPA, it is being substituted by other chemical compounds such as bisphenol F in some applications. Although, paints & coatings is the largest application of the resin, the growing demand of the resin in the wind turbine application is expected to become the fastest-growing market.

According to the estimates, the Asia-Pacific region led the market for phthalic anhydride with 57.0% share by volume at the global level in 2013, followed by Europe (20.6%), North America (17.0%), and Rest of the World (5.3%). Around 36.0% of the resin was estimated to be consumed for paints & coatings in 2013. For electrical & electronics and construction applications, the estimated share were 22.5% and 9.2% respectively.


The growth of the epoxy resin market has been studied through in-depth analysis of important factors that drive the market such as growth in the end-user industry, growing wind energy capacity installation with opportunities in green and sustainable epoxies, and growing demand for it in the aerospace industry. However, slow growth in the European and mature markets of the U.S. and Japan are proving to be the important restraining factors for the market.


About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.


This link:http://www.chemcd.com/news/3361.html

The ChemCD compiler finishing, shall not be reproduced without permission, for reprint please indicate the source。

comments powered by Disqus

Categories

Related News

Prime Therapeutics urges FDA to keep current, consistent naming conventions for biologics, biosimilars

Prime Therapeutics, LLC (Prime) has submitted comments to the U.S. Food and Drug Administration (FDA) in support of two citizen petitions on the naming of biosimilar drugs. Biosimilars are medically equivalent versions of biologics, used to treat complex illnesses such as cancer.

FDA Approves Pembrolizumab for Advanced Melanoma

Today the FDA approved Keytruda (pembrolizumab), a new treatment for advanced melanoma, the deadliest form of skin cancer. Melanoma patients have been waiting anxiously for this day, given the promising data that early studies have shown.

Epoxy Resin Market Worth $9.2 Billion by 2019

"Epoxy Resin market by Application (Coatings, Electronics, Construction, Wind Turbine, Composites, and Adhesives) and Geography - Trends & Forecast to 2019" by MarketsandMarkets, the market of epoxy resin is projected to grow from an estimated $5,995.8 million in 2013 to $9,219.1 million by 2019, with a CAGR of 7.4% between 2014 and 2019.

GSK receives FDA approval of an additional Promacta (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)

FDA has approved a supplemental New Drug Application (sNDA) for the once-daily use of Promacta(eltrombopag) in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST).

FDA Approves The Medicines Company's ORBACTIV™ (oritavancin) for Use in Acute Bacterial Skin and Skin Structure Infections

FDA Approves The Medicines Company's ORBACTIV? (oritavancin) for Use in Acute Bacterial Skin and Skin Structure Infections First and Only Single Dose Antibiotic for the Treatment of Skin Infections Caused by Susceptible Designated Gram-positive Bacteria ORBACTIV?U.S. Launch Expected in 2H/2014

AstraZeneca and QIAGEN enter collaboration to develop diagnostic test for lung cancer patients suitable for treatment with IRESSA

AstraZeneca today announced that it has entered into a collaboration with Netherlands-based QIAGEN to develop a non-invasive diagnostic test to identify non-small cell lung cancer (NSCLC) patients who are suitable for treatment with IRESSA?.

Scientists test nanoparticle 'alarm clock' to awaken immune systems put to sleep by cancer

Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells. Tumors protect themselves by tricking the immune system into accepting everything as normal, even while cancer cells are dividing and spreading.